LACTOLOGY FOUNDATION

Psyllium (ispaghula, psylla seeds; ATC A06AC01) is a bulk‑forming laxative that is not systemically absorbed and is considered compatible with breastfeeding, with negligible risk of toxicity to the breastfed infant when used in usual therapeutic doses.medpedia.framar+3

This monograph summarizes pharmacology, toxicology and lactation safety of medicines belonging to ATC class A06AC01, which comprises bulk‑producing laxatives based on psyllium/ispaghula (Plantago ovata) seed husk.mims+3

Pharmacology and clinical use

Psyllium husk consists of hydrophilic, largely non‑digestible polysaccharide fibers obtained from Plantago ovata seeds. In the intestinal lumen these fibers bind water, increase stool bulk and soften feces, thereby stimulating colonic peristalsis and facilitating defecation. Onset of laxative effect is typically within 12–24 hours, with maximal effect after 2–3 days of regular intake.wikipedia+2

Agents in class A06AC01 are indicated for chronic constipation and conditions where soft stools are desirable, such as anal fissures, hemorrhoids and the postoperative period after rectal or anal surgery. Psyllium is also used as a dietary fiber supplement to relieve mild diarrhea and to improve stool regularity.farmacotherapeutischkompas+2

Pharmacokinetics and transfer into breast milk

Psyllium acts locally in the gastrointestinal tract and is not significantly absorbed systemically. Because the active fibers remain within the gut lumen, they do not reach maternal plasma in relevant amounts and therefore cannot be secreted into breast milk. Drugs and lactation databases and national health authorities state that psyllium is acceptable during breastfeeding and does not pass into breast milk.drugsporphyria+3

Given the absence of systemic exposure, the relative infant dose (RID) via breast milk is expected to be essentially zero, and no pharmacological effect in the breastfed infant is anticipated. No specific data on psyllium concentrations in human milk have been published, but the mechanistic and pharmacokinetic profile strongly supports negligible transfer.ncbi.nlm.nih+1

Toxicology and adverse effects

Psyllium is generally well tolerated when taken with adequate fluid intake, but several adverse effects have been documented. Gastrointestinal reactions include abdominal pain, bloating, flatulence, nausea and, rarely, vomiting or diarrhea. If psyllium is taken with insufficient liquid, fecal impaction or intestinal obstruction can occur, particularly in predisposed patients.medpedia.framar+1

Allergic reactions to psyllium dust or ingestion have been reported, ranging from skin rash and urticaria to rhinitis, bronchospasm and, in rare cases, anaphylaxis. Such reactions are mediated by sensitization to plant proteins and may be more frequent in occupational exposure (e.g. pharmaceutical workers) than in patients using packaged preparations. There is no evidence of direct systemic toxicity for the mother or infant at recommended doses, beyond these local and hypersensitivity reactions.drugsporphyria+2

Contraindications and precautions in lactation

General contraindications include known hypersensitivity to psyllium, suspected or confirmed intestinal obstruction, megacolon, severe fecal stasis, unexplained abdominal pain, vomiting or rectal bleeding, and significant esophageal or gastrointestinal strictures. Psyllium should not be used in patients with difficulty swallowing or in those unable to increase fluid intake, due to the risk of obstruction.farmacotherapeutischkompas+1

In breastfeeding women, psyllium can be used at usual adult doses, provided that general contraindications are respected and adequate hydration is maintained. The main lactation‑specific precaution is indirect: severe maternal constipation or obstruction should prompt medical evaluation, but psyllium itself does not pose a direct toxic risk to the breastfed infant.sps+2

Drug interactions and clinical management during breastfeeding

By binding substances in the intestinal lumen, psyllium can delay or reduce the absorption of concomitantly administered oral medications such as vitamins, minerals and cardiac glycosides. To minimize this effect, it is advisable to administer other oral drugs at least 1–2 hours before or after psyllium.medpedia.framar+1

Preparations that inhibit gastrointestinal motility, or other swelling agents, should not be taken together with psyllium because of an increased risk of ileus and obstruction. These interaction mechanisms do not involve changes in breast milk composition and primarily affect maternal therapy; however, inadequate management of constipation in the mother can indirectly impair breastfeeding comfort and continuity.clevelandclinic+3

Overall lactation risk assessment

·        Maternal exposure: Psyllium is administered orally as granules, powder, sachets or oral suspensions, with typical adult doses of approximately 3.4–4 g one to three times daily, together with at least 150 ml of fluid per dose.ephor+2

·        Infant exposure via milk: Negligible, due to lack of systemic absorption and absence of transfer into breast milk.nhs+1

·        Documented effects in breastfed infants: No adverse effects have been reported in association with maternal psyllium use; products such as Fybogel are considered safe during breastfeeding by national health services.sps+1

·        Risk category (qualitative): Compatible with breastfeeding; no additional monitoring of the infant is usually required beyond routine clinical observation.ncbi.nlm.nih+2

For lactating patients with constipation, psyllium is often preferred over stimulant laxatives because of its benign systemic profile and very low interaction potential with the infant.ephor+2

Example dosing and practical advice (breastfeeding women)

In adults and adolescents over 12 years, one dose (e.g. one measuring spoon or one sachet, approximately 3.5 g) in 150–200 ml water one to three times daily is commonly used. Each dose should be stirred into liquid and swallowed immediately, followed by at least one additional glass of water. Psyllium should not be taken immediately before bedtime to reduce the risk of impaired esophageal transit in the supine position.ephor+2

Breastfeeding women should be advised to:

·        Maintain adequate daily fluid intake.

·        Separate psyllium administration from other oral medicines by at least one to two hours.farmacotherapeutischkompas+1

·        Stop psyllium and seek medical advice if new abdominal pain, vomiting, rectal bleeding or signs of allergy (rash, dyspnea, bronchospasm) occur.medpedia.framar+1